Staar Surgical (STAA) Shares Outstanding (Weighted Average) (2010 - 2026)

Staar Surgical (STAA) has 12 years of Shares Outstanding (Weighted Average) data on file, last reported at $49.9 million in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Weighted Average) rose 1.14% year-over-year to $49.9 million; the trailing twelve-month figure through Apr 2026 stood at $49.9 million (up 1.14% YoY), and the FY2026 full-year result was $49.6 million, up 0.9% from the prior year.
• Shares Outstanding (Weighted Average) for Q2 2026 stood at $49.9 million, up from $49.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $49.9 million in Q2 2026 and bottomed at $47.8 million in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $48.9 million (2024), against an average of $48.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) rose 1.65%; it then climbed 0.61% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $48.0 million in 2022, then gained by 1.12% to $48.5 million in 2023, then advanced by 1.24% to $49.1 million in 2024, then grew by 0.76% to $49.5 million in 2025, then rose by 0.83% to $49.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $49.9 million (Q2 2026), $49.6 million (Q1 2026), and $49.5 million (Q3 2025), per Business Quant data.

Peer Comparison